Lobbying Filing Details

Total Spending

$560,000

Activities

1

Lobbyists

3

Gov't Entities

2

Filing Information
Filing UUID:
9def3697-ec2e-4091-87a9-a0ce5df3e051
Type:
Q4 - 4th Quarter - Report
Period:
2018 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 18, 2019 at 7:43 PM
Income:
$0
Expenses:
$560,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: G. Joel Baise, Director, Government Relations
Registrant
WALGREEN COMPANY

Retail Pharmacy

WASHINGTON, District of Columbia
Client
WALGREEN COMPANY
District of Columbia, United States of America
Lobbying Activities (1)
Activity 1
Pharmacy

H.R. 592 / S. 109 - The Pharmacy and Medically Underserved Areas Enhancement Act, all provisions related to amending the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients in medically underserved communities, consistent with state scope of practice laws.

H.R. 3528 / S. 2460 and H.R. 6 - These bills would amend title XVIII of the Social Security Act to require e-prescribing under Part D of the Medicare program of prescription drugs that are controlled substances.

Issues related to American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; no legislation.

Lobbyists (3)
  • ALETHIA JACKSON
  • MR. EDWARD KALETA III
  • KATHARINE TROLLER BOND
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.